Search results
Better Generics Pharmaceutical Stock: Teva or Viatris?
Motley Fool· 1 year agoTeva Pharmaceutical Industries (NYSE: TEVA) and Viatris (NASDAQ: VTRS) are two of the top makers of...
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 months agoTeva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2023 Earnings Call Transcript January 31, 2024...
Teva Pharmaceutical: Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 6 months agoTeva Pharmaceutical Industries (NYSE:TEVA) is one of the leading companies in the healthcare sector, specializing in developing and commercializing...
Teva Pharmaceutical Soars After Inking More Than $4 Billion In Opioid Deals
Investor's Business Daily· 2 years agoTeva Pharmaceutical inked settlement deals worth upward of $4 billion for its role in the opioid...
TEVA Q1 Earnings Miss Estimates, Sales Beat, Stock Declines
Zacks via Yahoo Finance· 1 year agoTeva Pharmaceutical Industries Limited TEVA reported first-quarter 2023 adjusted earnings of 40...
Teva Guides To Its First Year Of Growth Since 2017 — But Shares Tumbled On This Caveat
Investor's Business Daily· 1 year agoTeva Pharmaceutical expects 2023 sales to grow for the first time in six years, but its outlook...
Teva Pharmaceutical Industries Ltd (TEVA) Reports Solid Growth in 2023 Earnings
GuruFocus.com via Yahoo Finance· 4 months agoRevenue Growth: TEVA reported a 7% increase in local currency terms for 2023, reaching $15.8...
Teva, GSK Put Up Bullish Fourth-Quarter Performances. Here's Where Novartis Fell Short.
Investor's Business Daily· 4 months agoTeva stock neared a profit-taking zone Wednesday, while GSK stock — a fellow pharma Goliath —...
Huntington's treatment helps Teva beat profit estimates as CEO eyes newer drug opportunities
Reuters via AOL· 10 months agoJERUSALEM (Reuters) -Teva Pharmaceutical Industries on Wednesday reported higher-than-expected...
TEVA Q4 Earnings and Revenues Surpass Estimates, Stock Up
Zacks via Yahoo Finance· 4 months agoTeva Pharmaceutical Industries Limited TEVA reported fourth-quarter 2023 adjusted earnings of $1 per...